We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+5.38%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$2.7B
AUM Growth
+$327M
Cap. Flow
+$250M
Cap. Flow %
9.26%
Top 10 Hldgs %
15.88%
Holding
688
New
182
Increased
151
Reduced
113
Closed
218

Top Sells

Rank Stock Value
1
INVH icon
Invitation Homes
INVH
+$41.8M
2
HIW icon
Highwoods Properties
HIW
+$26.5M
3
PGRE
Paramount Group
PGRE
+$23.7M
4
MAS icon
Masco
MAS
+$21.2M
5
HR icon
Healthcare Realty
HR
+$20.2M

Sector Composition

Rank Sector Weight
1 Real Estate 14.72%
2 Consumer Discretionary 10.88%
3 Energy 7.88%
4 Utilities 7.46%
5 Industrials 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WLL
451
DELISTED
Whiting Petroleum Corporation
WLL
$328K 0.01%
+200
New +$294K
FRED
452
DELISTED
Fred's Inc
FRED
$322K 0.01%
+50,000
New +$328K
INSY
453
DELISTED
Insys Therapeutics, Inc.
INSY
$306K 0.01%
34,500
-10,000
-22% -$103K
NVS icon
454
Novartis
NVS
$295B
$300K 0.01%
3,906
+36
+0.9% +$2.72K
F icon
455
Ford
F
$57.3B
$299K 0.01%
25,000
-126,935
-84% -$1.43M
MAT icon
456
Mattel
MAT
$4.17B
$285K 0.01%
18,400
-19,569
-52% -$350K
ABEO icon
457
Abeona Therapeutics
ABEO
$345M
$256K 0.01%
600
+200
+50% +$53.7K
STAA icon
458
STAAR Surgical
STAA
$1.16B
$249K 0.01%
20,000
-9,000
-31% -$100K
KRE icon
459
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
$219K 0.01%
+3,860
New +$207K
CRIS icon
460
Curis
CRIS
$9.53M
$186K 0.01%
63
RIGL icon
461
Rigel Pharmaceuticals
RIGL
$680M
$173K 0.01%
6,800
ELGX
462
DELISTED
Endologix Inc
ELGX
$167K 0.01%
3,750
-1,250
-25% -$57K
SIEN
463
DELISTED
Sientra, Inc.
SIEN
$154K 0.01%
+1,000
New +$117K
INSY
464
CALL
DELISTED
Insys Therapeutics, Inc.
INSY
$133K ﹤0.01%
+15,000
New +$155K
ADXS
465
DELISTED
Advaxis Inc
ADXS
$125K ﹤0.01%
2,000
ALIM
466
DELISTED
Alimera Sciences
ALIM
$108K ﹤0.01%
5,333
-267
-5% -$5.71K
CPRX
467
DELISTED
Catalyst Pharmaceutical
CPRX
$76K ﹤0.01%
30,000
-30,000
-50% -$82.3K
GERN icon
468
Geron
GERN
$911M
$44K ﹤0.01%
20,000
TNDM icon
469
Tandem Diabetes Care
TNDM
$1.17B
$15K ﹤0.01%
2,000
ABEV icon
470
PUT
Ambev
ABEV
$47.3B
-205,000
Closed -$1.13M
ADMA icon
471
ADMA Biologics
ADMA
$1.92B
-20,000
Closed -$74K
AEO icon
472
American Eagle Outfitters
AEO
$2.85B
-295,000
Closed -$3.56M
AFL icon
473
Aflac
AFL
$63.9B
-14,182
Closed -$551K
AIV
474
Aimco
AIV
$380M
-1,692,882
Closed -$9.69M
AJG icon
475
Arthur J. Gallagher & Co
AJG
$63.7B
-17,784
Closed -$1.02M

Similar funds

Weiss Multi-Strategy Advisers's Q3 2017 Portfolio in Review

As of Q3 2017, Weiss Multi-Strategy Advisers held 688 positions worth $2.7B, up 14% from $2.37B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Weiss Multi-Strategy Advisers deployed $250M of net new capital in Q3 2017, opening 182 new positions and adding to 151 existing holdings. Its largest new stake was American Homes 4 Rent: 1,577,113 shares worth $34.2M.

By sector, the portfolio is most concentrated in Real Estate at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Energy.

On the sell side, the largest reduction was Veris Residential, an estimated $19.8M trimmed.

  • Weiss Multi-Strategy Advisers's largest Q3 2017 buy was American Homes 4 Rent: 1,577,113 shares worth $34.2M.
  • Weiss Multi-Strategy Advisers added most to Boston Properties in Q3 2017, an estimated $23.9M increase.
  • Weiss Multi-Strategy Advisers's biggest Q3 2017 reduction was Veris Residential, cutting an estimated $19.8M.
  • Weiss Multi-Strategy Advisers fully exited Invitation Homes in Q3 2017, selling an estimated $41.8M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 16% of its $2.7B portfolio in Q3 2017.
  • Weiss Multi-Strategy Advisers opened 182 new positions and closed 218 in Q3 2017.
  • Weiss Multi-Strategy Advisers's portfolio value rose 14% quarter-over-quarter to $2.7B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2017, filed 14 Nov 2017.